Biology:Topiroxostat
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Trade names | Topiloric, Uriadec |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C13H8N6 |
| Molar mass | 248.249 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Topiroxostat (INN; trade names Topiloric, Uriadec) is a drug for the treatment of gout and hyperuricemia.[1] It was approved for use in Japan in June 2013.[1]
Topiroxostat is a xanthine oxidase inhibitor which reduces serum urate levels.[2]
References
- ↑ 1.0 1.1 New Drugs FY2013. Pharmaceuticals and Medical Devices Agency, Japan. http://www.pmda.go.jp/english/service/pdf/list/NewdrugsFY2013.pdf.
- ↑ "Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout". Clinical and Experimental Nephrology 18 (6): 876–84. December 2014. doi:10.1007/s10157-014-0935-8. PMID 24448692.
 |  |
